Why is QMS Medical Allied Services Ltd falling/rising?

Short-Term Price Movement and Market Context

QMS Medical Allied Services Ltd outperformed its sector by 10.17% on the day, a notable achievement given the broader market conditions. Over the past week, the stock has gained 2.61%, surpassing the Sensex’s 1.09% rise. However, the one-month and year-to-date returns remain negative at -1.67% and -1.23% respectively, though these losses are less severe than the Sensex’s declines of -2.38% and -3.10% over the same periods. This suggests that while the stock has struggled recently, it is showing signs of relative resilience.

Technical indicators reveal that the current price is above the 5-day and 20-day moving averages, signalling short-term bullish momentum. However, it remains below the 50-day, 100-day, and 200-day averages, indicating that the stock has yet to fully recover from its longer-term downtrend. Notably, investor participation has declined, with delivery volume on 29 Jan falling by 19.35% compared to the five-day average, which may imply cautious trading despite the price surge.

Fundamental Strengths Supporting the Rally

Despite the stock’s underwhelming returns over the past year (-17.48%) and three years (-52.18%), QMS Medical Allied Services Ltd has demonstrated improving profitability, with profits rising by 19.6% over the last twelve months. This profit growth contrasts with the stock’s price performance, suggesting a disconnect that may be attracting value-focused investors. The company’s return on capital employed (ROCE) stands at a respectable 13.6%, and it maintains an attractive valuation with an enterprise value to capital employed ratio of 1.5. These metrics indicate efficient capital utilisation and a potentially undervalued stock relative to its peers.

Institutional investors have also increased their stake by 1.6% in the previous quarter, now collectively holding 1.61% of the company. This growing institutional participation is significant, as these investors typically possess greater analytical resources and a longer-term investment horizon, which can lend credibility to the stock’s prospects and support price appreciation.

Challenges Tempering Optimism

However, the company’s recent quarterly earnings per share (EPS) of ₹1.61 is the lowest recorded, and interest expenses for the nine months ended September 2025 have surged by 93.17% to ₹6.22 crore. These factors contribute to flat results in the latest quarter, raising concerns about profitability pressures and cost management. Moreover, the stock has consistently underperformed the BSE500 benchmark over the last three years, reflecting structural challenges or market scepticism about its growth trajectory.

Balancing Valuation and Performance for Investors

The recent price surge in QMS Medical Allied Services Ltd appears to be driven by its attractive valuation metrics and improving profit figures, which may be encouraging investors to look past the company’s recent flat results and historical underperformance. The PEG ratio of 1.5 suggests that the stock’s price is reasonably aligned with its earnings growth, supporting the notion of a value opportunity. However, the elevated interest costs and weak quarterly EPS highlight ongoing risks that investors should monitor closely.

Liquidity remains adequate for trading, although the decline in delivery volume signals some caution among market participants. The stock’s position relative to moving averages indicates that while short-term momentum is positive, a sustained recovery will require overcoming resistance at longer-term averages.

In summary, QMS Medical Allied Services Ltd’s 10.62% rise on 30-Jan reflects a combination of undervaluation, profit growth, and increased institutional interest, set against a backdrop of operational challenges and historical underperformance. Investors should weigh these factors carefully when considering the stock’s medium to long-term prospects.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →